References
Meloni G, De Fabritiis P, Petti MC, Mandelli F . BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 1990; 75: 2282–2285.
Cheson BD, Bennett JM, Kopecky KJ et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes and reporting standards for therapeutic trials in acute myeloid leukemia. JCO 2003; 21: 4642–4649.
Meloni G, Diverio D, Vignetti M et al. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood 1997; 90: 1321–1325.
Nabhan C, Mehta J, Tallman MS . The role of bone marrow transplantation in acute promyelocytic leukaemia. Bone Marrow Transplant 2001; 28: 219–226.
Avvisati G, Lo Coco F, Diverio D et al. AIDA (all-trans retinoic acid+idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie EMatologiche Maligne dell’Adulto (GIMEMA) pilot study. Blood 1996; 88: 1390–1398.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Capria, S., Latagliata, R., Avvisati, G. et al. BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. Bone Marrow Transplant 36, 83–84 (2005). https://doi.org/10.1038/sj.bmt.1704995
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704995
- Springer Nature Limited
This article is cited by
-
Traitement des leucémies aiguës promyélocytaires de l’adulte
Oncologie (2008)